Ads
related to: Pfizer
Search results
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots
Barrons.com· 7 days agoAfter disappointing sales for their Covid vaccines last year, Moderna, Novavax, and Pfizer are...
Pfizer's $1.5B cuts; Biogen's $1.15B buyout; AstraZeneca's $80B ambition; RNA startup merger; and...
Endpoints News· 2 days agoWant this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. Whether you will be in San Diego for BIO, we hope you will join ...
Pfizer to Cut Costs in Multi-Year Effort
Morningstar· 5 days agoBy Josh Beckerman Pfizer is launching a multi-year cost-reduction program. The company said first phase is focused on operational efficiencies and is expected to deliver savings ...
Got $500? 3 Pharma Stocks to Buy and Hold Forever | The Motley Fool
The Motley Fool· 1 day agoWith that in mind, let's examine three leading pharma stocks that are ripe for buying today and...
Pfizer recalls 5 drug lots for potential packaging error
Becker’s Hospital Review· 4 days agoThree lots of buprenorphine hydrochloride, used for pain management, and two lots of labetalol hydrochloride, indicated for blood pressure control in severe hypertension cases, were recalled ...
Lady Gaga Reveals She Played 5 Shows With COVID: 'Didn't Want To Let All The Fans Down'
HuffPost via Yahoo News· 3 days agoThe confession at her "Gaga Chromatica Ball" concert film premiere Thursday was met with raucous...
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 6 days agoA decade ago, as British drugmaker AstraZeneca fought off a hostile takeover bid by Pfizer, CEO Pascal Soriot made a big promise: The company, he said,...
Estrogen-Only Therapy for Menopausal Symptoms Increases Ovarian Cancer Risk
MedPage Today· 3 days agoUse of conventional hormonal therapy for menopausal symptoms doubled the long-term risk of ovarian...
3 Biotech Stocks to Buy on the Dip: May 2024
InvestorPlace· 4 days agoDespite their exciting growth potential and undeniable rewards, investors have been selling these stocks, causing a slight dip in price. Pfizer (NYSE:PFE) is a giant in biopharma ...
3 Blue-Chip Stocks to Buy on the Dip: May 2024
InvestorPlace· 6 days agoWhile the latest Commerce Department report showed a notable deceleration in GDP growth, experts attribute much of this to robust spending on imported...
